flunarizine
Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
Ligand Summary
UNII: R7PLA2DM0J
PubChem: 941361
ChEMBL: CHEMBL30008
DrugCentral: 1200
LyCHI: FH1AY465SJH3
Target Activities
CACNA1I
Voltage-dependent T-type calcium channel subunit alpha-1I
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | 6.08 | Bioorg. Med. Chem. Lett., (2011) 21:1:215 | ||||
Kd | 6.08 | Bioorg. Med. Chem., (2010) 18:16:5938 | ||||
Kd | 6.08 | BLOCKER | ||||
CACNA1G
Voltage-dependent T-type calcium channel subunit alpha-1G
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | 6.28 | Bioorg. Med. Chem. Lett., (2011) 21:1:215 | ||||
Kd | 6.28 | Bioorg. Med. Chem., (2010) 18:16:5938 | ||||
Kd | 6.28 | BLOCKER | ||||
SLC6A4
Sodium-dependent serotonin transporter
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 6.3 | None, None:None:None | ||||
Ki | 6.58 | None, None:None:None | ||||
SLC6A3
Sodium-dependent dopamine transporter
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 6.23 | None, None:None:None | ||||
Ki | 6.33 | None, None:None:None | ||||
DRD3
D(3) dopamine receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 7.01 | None, None:None:None | ||||
Ki | 7.48 | None, None:None:None | ||||
CACNA1H
Voltage-dependent T-type calcium channel subunit alpha-1H
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | 5.44 | Bioorg. Med. Chem., (2010) 18:16:5938 | ||||
Kd | 5.44 | BLOCKER | ||||
SIGMAR1
Sigma non-opioid intracellular receptor 1
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 7.6 | None, None:None:None | ||||
Ki | 8 | None, None:None:None | ||||
KCNH2
Potassium voltage-gated channel subfamily H member 2
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 6.22 | None, None:None:None | ||||
Ki | 6.3 | None, None:None:None | ||||
CACNA1B
Voltage-dependent N-type calcium channel subunit alpha-1B
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 5.78 | Bioorg. Med. Chem. Lett., (2007) 17:3:662 | ||||
HRH1
Histamine H1 receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.75 | None, None:None:None | ||||
ADRA2C
Alpha-2C adrenergic receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | 7.5 | None, None:None:None | ||||